Advertisement
International
Subscribe to International
View Sample

FREE Email Newsletter

Novartis hosts eighth BioCamp for future biotech leaders

August 30, 2011 2:47 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Novartis, which has more than 2,300 employees in Cambridge, opened its eighth annual International Biotechnology Leadership Camp (BioCamp), bringing together biotechnology and business experts, in Basel, Switzerland.

Rotavirus vaccination of infants also protects unvaccinated older children and adults

August 29, 2011 10:47 pm | by EurekAlert | News | Comments

(Infectious Diseases Society of America) Vaccinating infants against rotavirus also prevents serious disease in unvaccinated older children and adults, according to a study by the Centers for Disease Control and Prevention. This helps reduce rotavirus-related hospital costs in...

Watching viruses 'friend' a network

August 29, 2011 10:46 pm | by EurekAlert | News | Comments

(American Friends of Tel Aviv University) PiggyDemic, an application developed by Dr. Gal Almogy and professor Nir Ben-Tal of Tel Aviv University, allows Facebook users to "infect" their friends with a simulated virus or become infected themselves. This will allow researchers to...

Advertisement

Differences in cell response could explain higher rates of hypertension in African-Americans

August 29, 2011 6:47 pm | by EurekAlert | News | Comments

(Temple University) Kinesiology professor Michael Brown has found that differences in the way African-American cells respond to inflammation could be a cause of higher rates of hypertension among this group.

University of Houston hosts book symposium on 'Making War and Minting Christians,' Sept. 8

August 29, 2011 11:47 am | by EurekAlert | News | Comments

(University of Houston) The University of Houston department of history will host a symposium featuring a new book by UH professor Todd Romero, "Making War and Minting Christians: Masculinity, Religion, and Colonialism in Early New England," on Thursday, Sept. 8, at 4 p.m. in the...

Scientists find new drug candidates for set of protein-folding diseases

August 29, 2011 11:47 am | by EurekAlert | News | Comments

(Scripps Research Institute) Collaborating researchers at Stanford University and the Scripps Research Institute have identified chemical compounds that show promise as potential therapeutics for a set of medical conditions caused by the abnormal clumping together of a protein...

Bilingual babies' vocabulary linked to early brain differentiation

August 28, 2011 8:47 pm | by EurekAlert | News | Comments

(University of Washington) Researchers at the University of Washington are investigating the brain mechanisms that contribute to infants' prowess at learning languages, with the hope that the findings could boost bilingualism in adults, too. In a new study, the researchers report...

New research validates clinical importance of leukemia stem cells

August 28, 2011 2:47 pm | by EurekAlert | News | Comments

(University Health Network) Research published today focuses on patients and shows that acute myeloid leukemia (AML) contains rare cells with stem cell properties, called leukemia stem cells (LSC), that are better at predicting clinical outcome than the majority of AML cells,...

Advertisement

Stanford researchers invent sutureless method for joining blood vessels

August 28, 2011 2:47 pm | by EurekAlert | News | Comments

(Stanford University Medical Center) Reconnecting severed blood vessels is mostly done the same way today -- with sutures -- as it was 100 years ago, when the French surgeon Alexis Carrel won a Nobel Prize for advancing the technique. Now, a team of researchers at the Stanford...

Apixaban superior to warfarin for preventing stroke, reducing bleeding and saving lives

August 27, 2011 10:46 pm | by EurekAlert | News | Comments

(Duke University Medical Center) A large-scale trial finds that apixaban, a new anticoagulant drug, is superior to the standard drug warfarin for preventing stroke and systemic embolism in patients with atrial fibrillation. Moreover, apixaban results in substantially less bleeding...

ShoulderFlex Massager by King International: Safety Communication - Risk of Strangulation

August 26, 2011 10:50 am | News | Comments

Hair, clothing, and jewelry can become entangled in the massage device and cause serious injury or death.

inVentiv Health launches London unit

August 25, 2011 3:57 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Burlington life sciences consulting and services firm inVentiv Health Inc. says it has opened a new company in London called inVentiv Health Communications/Europe that combines a number of European subsidiaries and functions.

Charles River Labs shuffles units, top personnel

August 25, 2011 3:57 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Charles River Laboratories International Inc. (NYSE: CRL) moved around business units, unifying its Research Models and Services (RMS) and Preclinical Services (PCS) businesses, the company announced in a release late yesterday

Advertisement

Ariad gets $25M milestone payment from Merck

August 18, 2011 7:52 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ariad Pharmaceuticals Inc. will be getting a $25 million milestone payment from partner Merck, as the bone cancer drug they are working on has moved further toward approval in the European Union, just months after the deal between the two companies was expanded.

Important Information on the Medical Device User Fee Rates for FY2012 (Updated)

August 14, 2011 6:42 am | News | Comments

This letter is to notify you of the fiscal year 2012, (October 1, 2011-September 30, 2012), fee rates and payment procedures for medical device user fees payable to the United States Food and Drug Administration, (US FDA).

New Covidien chief Almeida eyes staff growth outside U.S.

August 5, 2011 9:52 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Covidien plc CEO José E. Almeida said Thursday that the life sciences company is likely to add workers outside the United States, as a growing portion of the company's revenues come from international sales.

What shapes a bone?

August 5, 2011 6:49 am | by EurekAlert | News | Comments

(Johns Hopkins Medical Institutions) Researchers at Johns Hopkins found that use over time and not just genetics informs the structure of jaw bones in human populations. The researchers say these findings may be used to predict the diet of an ancient population, even if little...

First scorpion antivenom approved by FDA

August 4, 2011 6:49 pm | by EurekAlert | News | Comments

(University of Arizona Health Sciences Center) The highest concentration of dangerous bark scorpions in the United States is in Arizona, where about 8,000 scorpion stings occur each year. Several hundred of these result in serious nerve poisoning and require medical treatment....

Ariad cancer drug target awaits EU approval

August 1, 2011 8:47 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Ariad Pharmaceuticals Inc. has announced its partner, Merck & Co. Inc., has sent the companies' joint cancer drug candidate, ridaforolimus, to European regulators for approval, and is due a $25 million milestone payment from Merck, in connection with the partnership.

Boston Scientific plans $1B stock buyback, up to 1,400 job cuts

July 28, 2011 5:50 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Just one day after announcing plans to invest heavily in China, Boston Scientific Corp. has won approval from its board to buy back $1 billion worth of common stock. The news comes as the company revealed in its second-quarter earnings report that it will cut between 1,200 and 1,400 jobs...

Bancel appointed BG Medicine chairman

July 27, 2011 10:45 am | by Mass High Tech: The Journal of New England Technology | News | Comments

BG Medicine Inc., a maker of biomarker-based diagnostics in Waltham, has named Stéphane Bancel as executive chairman of the company's board of directors. Former chairman and BG Medicine founder Noubar Afeyan will still hold a board seat.

ACT gains exclusive license for blood-related stem cell tech

July 21, 2011 10:42 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Advanced Cell Technology Inc. is gaining an exclusive license to hemangioblast cell technology, for potential use in vascular repair, from Stem Cell & Regenerative Medicine International, a joint venture the Marlborough company formed with South Korea-based CHA Bio & Diostech Co Ltd.

UK's IDBS sets up U.S. Healthcare headquarters in Burlington

July 14, 2011 5:37 am | by Mass High Tech: The Journal of New England Technology | News | Comments

IDBS, a UK-based software company focused on the R&D and healthcare sectors, has established a U.S. Healthcare headquarters at its existing office in Burlington, where it also is expanding its staff.

Sectra sells MicroDose business to Philips for up to $100M

June 27, 2011 5:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Sectra Imtec AB, a Swedish firm with U.S. headquarters in Connecticut, has agreed to sell the bulk of its MicroDose mammography system for a potential $100 million to Dutch tech giant Royal Philips Electronics.

Shire drug approved by European regulators for Lexington manufacturing

June 24, 2011 11:36 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Shire plc's new Lexington manufacturing site has won approval from the European Medicines Agency for the purification of the company's Fabry disease treatment Replagal.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading